Congressional opioid efforts targeting Medicare, limits on new prescriptions
Published by McKnight’s Long-Term Care News
A bipartisan group of senators introduced legislation Tuesday that would set a three-day initial prescribing limit on opioids for acute pain and increase recovery services and availability for addicts.
The legislation would change policies and make more funding available through the $6 billion earmarked for opioids and mental health treatment in a two-year budget deal struck last month.
The Senior Care Pharmacy Coalition urged lawmakers to stick with the precedent established in 2016 and exempt long-term care facilities from the proposed three-day limit. The current version only includes an exception for hospice care.
“Patients in long-term care settings are at very low risk for opioid abuse, and those prescribed opioids suffer intense and severe pain which mean that some dispensing limits inadvertently threaten effective pain management,” said Alan G. Rosenbloom, SCPC president and CEO.
One in three participants in Medicare’s prescription drug program received a prescription for opioids in 2016, according to the Office of Inspector General. Across the country, overdose deaths increased nearly 28% from 2015 to 2016, according to the latest data from the Centers for Disease Control and Prevention.
The House Energy and Commerce Committee held its first of three hearings Wednesday to discuss legislation, while the Ways and Means Committee has already made it clear Medicare’s handling of opioids will be in its sights.
The committee has asked insurers, benefit managers, providers and prescribers to submit information by March 15 that addresses how Medicare can help stem the epidemic. Members specifically want information on overprescribing, data tracking, treatment, communication and education, The Hill reported.
Recent Posts
-
SCPC Releases Statement in Support of Government Accountability Office (GAO) Report on the Inflation Reduction Act
SCPC has repeatedly warned about the impact of the Inflation Reduction Act’s (IRA) mandatory Medicare drug price negotiations on LTC pharmacies and the millions of vulnerable seniors they serve. We are glad the Government Accountability Office (GAO) is examining how these policies are affecting pharmacies, particularly LTC pharmacies, which already operate under a broken reimbursement model that often requires them to dispense many of the most commonly used medications at a loss.
-
SCPC Applauds President Trump’s Executive Order Calling on HHS and Congress to Improve the IRA, Rein In PBMs and Lower Drug Costs
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care (LTC) pharmacy community, released the following statement applauding President Trump’s recent Executive Order aimed at improving the Inflation Reduction Act (IRA), lowering drug prices and addressing the harmful actions of PBMs. “For far too long, pharmacy benefit managers (PBMs) have taken […]
-
60 percent of LTC pharmacies warn of closure amid major drug pricing changes
Facing deep losses on high-demand medications, 85% of long-term care pharmacies say they will limit essential services and 60% will close locations without changes to Medicare drug pricing efforts. Those are among the “unintended consequences” revealed in a Senior Care Pharmacy Coalition survey released Wednesday. The trade association has been increasingly vocal about pricing changes set to go into effect in January.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.